Adamis Pharmaceuticals competitorsClear all

Adamis Pharmaceuticals's top competitors include Retrophin, Palatin Technologies, GBT (Global Blood Therapeutics) and Omeros.
Adamis Pharmaceuticals
Adamis Pharmaceuticals
Adamis Pharmaceuticals Corporation is a specialty biopharmaceuticals company focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease.
Retrophin
Retrophin
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Palatin Technologies
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Omeros
Omeros
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
Founding Date
Founding Date
2006
Founding Date
2011
Founding Date
1986
Founding Date
2012
Founding Date
1994
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
San Diego, US HQ
Dublin, IE
Cambridge, US
Locations
Cranbury Township, US HQ
Locations
South San Francisco, US HQ
Locations
Seattle, US HQ
Employees
Employees
15241% increase
Employees
2213% increase
Employees
185% decrease
Employees
352106% increase
Employees
2589% increase
Valuation ($)
Valuation ($)
67.4 m
Valuation ($)
930.6 m
Valuation ($)
109.2 m
Valuation ($)
3.3 b
Valuation ($)
620.9 m
Twitter followers
Twitter followers
131
Twitter followers
14
Twitter followers
530
Twitter followers
1.5 k
Twitter followers
240
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
65
Number of tweets (last 30 days)
3
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.2
Average likes per tweet (last 30 days)
18.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
89.23%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
350598
Alexa Website Rank
302733
Alexa Website Rank
271668
Alexa Website Rank
488148
Alexa Website Rank
337813
Employee Rating
Employee Rating
1
Employee Rating
4.2
Employee Rating
4
Employee Rating
4.8
Employee Rating
3.3

Financial

Revenue (est.)
Revenue (est.)
$22.1m (FY, 2019)
Revenue (est.)
$175.3m (FY, 2019)
Revenue (est.)
$60.3m (FY, 2019)
Revenue (est.)
$2.1m (FY, 2019)
Revenue (est.)
$111.8m (FY, 2019)
Cost of goods
Cost of goods
$15.5m (FY, 2019)
Cost of goods
$5.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
$48k (FY, 2019)
Cost of goods
$865k (FY, 2019)
Gross profit
Gross profit
$6.6m (FY, 2019)
Gross profit
$170.1m (FY, 2019)
Gross profit
N/A
Gross profit
$2.1m (FY, 2019)
Gross profit
$110.9m (FY, 2019)
Net income
Net income
($29.3m) (FY, 2019)
Net income
($146.4m) (FY, 2019)
Net income
$35.8m (FY, 2019)
Net income
($266.8m) (FY, 2019)
Net income
($84.5m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 16.4m
Total funding raised
$ 116m
Total funding raised
$ 104.2m
Total funding raised
$ 88.7m
Total funding raised
$ 354.8m
For sources of this data, please see the company profile

View company profiles

Retrophin
HQ
San Diego, US
Employees
221↑ 3% increase

Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Palatin Technologies
HQ
Cranbury Township, US
Employees
18↓ 5% decrease

Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company
Omeros
HQ
Seattle, US
Employees
258↑ 9% increase

Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

View company